Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Long-term effect of gene therapy on Leber's congenital amaurosis.

Bainbridge JW, Mehat MS, Sundaram V, Robbie SJ, Barker SE, Ripamonti C, Georgiadis A, Mowat FM, Beattie SG, Gardner PJ, Feathers KL, Luong VA, Yzer S, Balaggan K, Viswanathan A, de Ravel TJ, Casteels I, Holder GE, Tyler N, Fitzke FW, Weleber RG, Nardini M, Moore AT, Thompson DA, Petersen-Jones SM, Michaelides M, van den Born LI, Stockman A, Smith AJ, Rubin G, Ali RR.

N Engl J Med. 2015 May 14;372(20):1887-97. doi: 10.1056/NEJMoa1414221. Epub 2015 May 4.

2.

Scotopic and Photopic Microperimetry in Patients With Reticular Drusen and Age-Related Macular Degeneration.

Steinberg JS, Fitzke FW, Fimmers R, Fleckenstein M, Holz FG, Schmitz-Valckenberg S.

JAMA Ophthalmol. 2015 Jun;133(6):690-7. doi: 10.1001/jamaophthalmol.2015.0477.

PMID:
25811917
3.

Dark-adaptation functions in molecularly confirmed achromatopsia and the implications for assessment in retinal therapy trials.

Aboshiha J, Luong V, Cowing J, Dubis AM, Bainbridge JW, Ali RR, Webster AR, Moore AT, Fitzke FW, Michaelides M.

Invest Ophthalmol Vis Sci. 2014 Aug 28;55(10):6340-9. doi: 10.1167/iovs.14-14910.

4.

A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations.

Fujinami K, Lois N, Mukherjee R, McBain VA, Tsunoda K, Tsubota K, Stone EM, Fitzke FW, Bunce C, Moore AT, Webster AR, Michaelides M.

Invest Ophthalmol Vis Sci. 2013 Dec 17;54(13):8181-90. doi: 10.1167/iovs.13-12104.

PMID:
24265018
5.

Comparison of fundus autofluorescence with photopic and scotopic fine matrix mapping in patients with retinitis pigmentosa: 4- to 8-year follow-up.

Robson AG, Lenassi E, Saihan Z, Luong VA, Fitzke FW, Holder GE, Webster AR.

Invest Ophthalmol Vis Sci. 2012 Sep 14;53(10):6187-95. doi: 10.1167/iovs.12-10195.

PMID:
22899761
6.

Differential modulation of retinal degeneration by Ccl2 and Cx3cr1 chemokine signalling.

Luhmann UF, Lange CA, Robbie S, Munro PM, Cowing JA, Armer HE, Luong V, Carvalho LS, MacLaren RE, Fitzke FW, Bainbridge JW, Ali RR.

PLoS One. 2012;7(4):e35551. doi: 10.1371/journal.pone.0035551. Epub 2012 Apr 24.

7.

Imaging apoptosis in the eye.

Cordeiro MF, Migdal C, Bloom P, Fitzke FW, Moss SE.

Eye (Lond). 2011 May;25(5):545-53. doi: 10.1038/eye.2011.64. Epub 2011 Mar 25.

8.

Retinal specific measurement of dark-adapted visual function: validation of a modified microperimeter.

Crossland MD, Luong VA, Rubin GS, Fitzke FW.

BMC Ophthalmol. 2011 Feb 8;11:5. doi: 10.1186/1471-2415-11-5.

9.

Localisation and significance of in vivo near-infrared autofluorescent signal in retinal imaging.

Schmitz-Valckenberg S, Lara D, Nizari S, Normando EM, Guo L, Wegener AR, Tufail A, Fitzke FW, Holz FG, Cordeiro MF.

Br J Ophthalmol. 2011 Aug;95(8):1134-9. doi: 10.1136/bjo.2010.189498. Epub 2010 Sep 29.

PMID:
20881028
10.

Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo.

Cordeiro MF, Guo L, Coxon KM, Duggan J, Nizari S, Normando EM, Sensi SL, Sillito AM, Fitzke FW, Salt TE, Moss SE.

Cell Death Dis. 2010;1:e3. doi: 10.1038/cddis.2009.3.

11.

The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages.

Luhmann UF, Robbie S, Munro PM, Barker SE, Duran Y, Luong V, Fitzke FW, Bainbridge JW, Ali RR, MacLaren RE.

Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5934-43. doi: 10.1167/iovs.09-3462. Epub 2009 Jul 2.

12.

Functional aspects of drusen regression in age-related macular degeneration.

Sallo FB, Rechtman E, Peto T, Stanescu-Segall D, Vogt G, Bird AC, Fitzke FW.

Br J Ophthalmol. 2009 Oct;93(10):1345-50. doi: 10.1136/bjo.2008.150334. Epub 2009 Jun 16.

PMID:
19535356
13.

[In vivo imaging of retinal cell apoptosis following acute light exposure].

Schmitz-Valckenberg S, Guo L, Cheung W, Moss SE, Fitzke FW, Cordeiro MF.

Ophthalmologe. 2010 Jan;107(1):22-9. doi: 10.1007/s00347-009-1952-y. German.

PMID:
19499229
14.

Structural and functional changes over time in MacTel patients.

Schmitz-Valckenberg S, Ong EE, Rubin GS, Peto T, Tufail A, Egan CA, Bird AC, Fitzke FW.

Retina. 2009 Oct;29(9):1314-20. doi: 10.1097/IAE.0b013e3181a4d2f1.

PMID:
19491718
15.

Post-capsulotomy dysphotopsia in monofocal versus multifocal lenses.

Allen R, Ho-Yen GO, Beckingsale AB, Fitzke FW, Sciscio AG, Saleh GM.

Clin Exp Optom. 2009 Mar;92(2):104-9. doi: 10.1111/j.1444-0938.2008.00345.x. Epub 2008 Nov 28.

16.

Evaluation of autofluorescence imaging with the scanning laser ophthalmoscope and the fundus camera in age-related geographic atrophy.

Schmitz-Valckenberg S, Fleckenstein M, Göbel AP, Sehmi K, Fitzke FW, Holz FG, Tufail A.

Am J Ophthalmol. 2008 Aug;146(2):183-92. doi: 10.1016/j.ajo.2008.04.006. Epub 2008 Jun 2.

PMID:
18514607
17.

Effect of gene therapy on visual function in Leber's congenital amaurosis.

Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, Viswanathan A, Holder GE, Stockman A, Tyler N, Petersen-Jones S, Bhattacharya SS, Thrasher AJ, Fitzke FW, Carter BJ, Rubin GS, Moore AT, Ali RR.

N Engl J Med. 2008 May 22;358(21):2231-9. doi: 10.1056/NEJMoa0802268. Epub 2008 Apr 27.

18.

Characterisation of the macular dystrophy in patients with the A3243G mitochondrial DNA point mutation with fundus autofluorescence.

Rath PP, Jenkins S, Michaelides M, Smith A, Sweeney MG, Davis MB, Fitzke FW, Bird AC.

Br J Ophthalmol. 2008 May;92(5):623-9. doi: 10.1136/bjo.2007.131177.

19.

Glare and halo with refractive correction.

Allen RJ, Saleh GM, Litwin AS, Sciscio A, Beckingsale AB, Fitzke FW.

Clin Exp Optom. 2008 Mar;91(2):156-60.

20.

Correlation of functional impairment and morphological alterations in patients with group 2A idiopathic juxtafoveal retinal telangiectasia.

Schmitz-Valckenberg S, Fan K, Nugent A, Rubin GS, Peto T, Tufail A, Egan C, Bird AC, Fitzke FW.

Arch Ophthalmol. 2008 Mar;126(3):330-5. doi: 10.1001/archopht.126.3.330.

PMID:
18332311
21.

Real-time in vivo imaging of retinal cell apoptosis after laser exposure.

Schmitz-Valckenberg S, Guo L, Maass A, Cheung W, Vugler A, Moss SE, Munro PM, Fitzke FW, Cordeiro MF.

Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2773-80. doi: 10.1167/iovs.07-1335. Epub 2008 Feb 15.

22.

Macular and retinal dysfunction of unknown origin in adults with normal fundi: evidence for an autoimmune pathophysiology.

Mantel I, Ramchand KV, Holder GE, Ohbayashi M, Morohoshi K, Patel N, Toda M, Fitzke FW, Bird AC, Ono SJ.

Exp Mol Pathol. 2008 Apr;84(2):90-101. doi: 10.1016/j.yexmp.2007.10.006. Epub 2007 Nov 9. Erratum in: Exp Mol Pathol. 2009 Oct;87(2):166.

PMID:
18255057
23.

Functional characteristics of patients with retinal dystrophy that manifest abnormal parafoveal annuli of high density fundus autofluorescence; a review and update.

Robson AG, Michaelides M, Saihan Z, Bird AC, Webster AR, Moore AT, Fitzke FW, Holder GE.

Doc Ophthalmol. 2008 Mar;116(2):79-89. Epub 2007 Nov 6. Review.

24.

Assessment of rat and mouse RGC apoptosis imaging in vivo with different scanning laser ophthalmoscopes.

Maass A, von Leithner PL, Luong V, Guo L, Salt TE, Fitzke FW, Cordeiro MF.

Curr Eye Res. 2007 Oct;32(10):851-61.

25.

Functional correlates of fundus autofluorescence abnormalities in patients with RPGR or RIMS1 mutations causing cone or cone rod dystrophy.

Robson AG, Michaelides M, Luong VA, Holder GE, Bird AC, Webster AR, Moore AT, Fitzke FW.

Br J Ophthalmol. 2008 Jan;92(1):95-102. Epub 2007 Oct 25.

PMID:
17962389
26.

Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction.

Coffey PJ, Gias C, McDermott CJ, Lundh P, Pickering MC, Sethi C, Bird A, Fitzke FW, Maass A, Chen LL, Holder GE, Luthert PJ, Salt TE, Moss SE, Greenwood J.

Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16651-6. Epub 2007 Oct 5.

27.

Targeting amyloid-beta in glaucoma treatment.

Guo L, Salt TE, Luong V, Wood N, Cheung W, Maass A, Ferrari G, Russo-Marie F, Sillito AM, Cheetham ME, Moss SE, Fitzke FW, Cordeiro MF.

Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13444-9. Epub 2007 Aug 7.

28.

Exploration of the psychophysics of a motion displacement hyperacuity stimulus.

Verdon-Roe GM, Westcott MC, Viswanathan AC, Fitzke FW, Garway-Heath DF.

Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4847-55.

PMID:
17065497
29.

Maculopathy due to the R345W substitution in fibulin-3: distinct clinical features, disease variability, and extent of retinal dysfunction.

Michaelides M, Jenkins SA, Brantley MA Jr, Andrews RM, Waseem N, Luong V, Gregory-Evans K, Bhattacharya SS, Fitzke FW, Webster AR.

Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3085-97.

PMID:
16799055
30.

Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity.

Robson AG, Saihan Z, Jenkins SA, Fitzke FW, Bird AC, Webster AR, Holder GE.

Br J Ophthalmol. 2006 Apr;90(4):472-9.

31.

Age-related macular disease: how to assess the retina using scanning laser techniques?

Bellmann C, Kabanarou SA, Sahel JA, Rubin GS, Fitzke FW.

Aging Clin Exp Res. 2005 Dec;17(6):435-44. Review.

PMID:
16485860
32.

Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo.

Guo L, Salt TE, Maass A, Luong V, Moss SE, Fitzke FW, Cordeiro MF.

Invest Ophthalmol Vis Sci. 2006 Feb;47(2):626-33.

33.

Autofluorescence imaging of choroidal neovascularization due to age-related macular degeneration.

Dandekar SS, Jenkins SA, Peto T, Scholl HP, Sehmi KS, Fitzke FW, Bird AC, Webster AR.

Arch Ophthalmol. 2005 Nov;123(11):1507-13.

PMID:
16286612
34.

Comparison of fundus autofluorescence and minimum-motion measurements of macular pigment distribution profiles derived from identical retinal areas.

Robson AG, Harding G, van Kuijk FJ, Pauleikhoff D, Holder GE, Bird AC, Fitzke FW, Moreland JD.

Perception. 2005;34(8):1029-34.

PMID:
16178159
35.

Classification of fundus autofluorescence patterns in early age-related macular disease.

Bindewald A, Bird AC, Dandekar SS, Dolar-Szczasny J, Dreyhaupt J, Fitzke FW, Einbock W, Holz FG, Jorzik JJ, Keilhauer C, Lois N, Mlynski J, Pauleikhoff D, Staurenghi G, Wolf S.

Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3309-14.

PMID:
16123434
36.

En face optical coherence tomography: a new method to analyse structural changes of the optic nerve head in rat glaucoma.

Guo L, Tsatourian V, Luong V, Podoleanu AG, Jackson DA, Fitzke FW, Cordeiro MF.

Br J Ophthalmol. 2005 Sep;89(9):1210-6. Erratum in: Br J Ophthalmol. 2005 Nov;89(11):1545. Podolean, AG [corrected to Podoleanu, AG].

37.

High resolution imaging of fluorescein patterns in RCS rat retinae and their direct correlation with histology.

Zambarakji HJ, Keegan DJ, Holmes TM, Halfyard AS, Villegas-Perez MP, Charteris DG, Fitzke FW, Greenwood J, Lund RD.

Exp Eye Res. 2006 Jan;82(1):164-71. Epub 2005 Jul 27.

PMID:
16054136
38.

A detailed phenotypic study of "cone dystrophy with supernormal rod ERG".

Michaelides M, Holder GE, Webster AR, Hunt DM, Bird AC, Fitzke FW, Mollon JD, Moore AT.

Br J Ophthalmol. 2005 Mar;89(3):332-9.

39.

A detailed study of the phenotype of an autosomal dominant cone-rod dystrophy (CORD7) associated with mutation in the gene for RIM1.

Michaelides M, Holder GE, Hunt DM, Fitzke FW, Bird AC, Moore AT.

Br J Ophthalmol. 2005 Feb;89(2):198-206.

40.

Pointwise linear progression criteria and the detection of visual field change in a glaucoma trial.

Wilkins MR, Fitzke FW, Khaw PT.

Eye (Lond). 2006 Jan;20(1):98-106.

PMID:
15650759
41.

Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix.

Guo L, Moss SE, Alexander RA, Ali RR, Fitzke FW, Cordeiro MF.

Invest Ophthalmol Vis Sci. 2005 Jan;46(1):175-82.

42.

Acute zonal occult outer retinopathy: towards a set of diagnostic criteria.

Francis PJ, Marinescu A, Fitzke FW, Bird AC, Holder GE.

Br J Ophthalmol. 2005 Jan;89(1):70-3.

43.

Comparison of fundus autofluorescence with photopic and scotopic fine-matrix mapping in patients with retinitis pigmentosa and normal visual acuity.

Robson AG, Egan CA, Luong VA, Bird AC, Holder GE, Fitzke FW.

Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4119-25.

PMID:
15505064
44.

Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration.

Cordeiro MF, Guo L, Luong V, Harding G, Wang W, Jones HE, Moss SE, Sillito AM, Fitzke FW.

Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13352-6. Epub 2004 Aug 30.

45.

A practical approach to measuring the visual field component of fitness to drive.

Crabb DP, Fitzke FW, Hitchings RA, Viswanathan AC.

Br J Ophthalmol. 2004 Sep;88(9):1191-6.

46.

Congenital stationary night blindness and a "Schubert-Bornschein" type electrophysiology in a family with dominant inheritance.

Kabanarou SA, Holder GE, Fitzke FW, Bird AC, Webster AR.

Br J Ophthalmol. 2004 Aug;88(8):1018-22.

47.

Fundus autofluorescence in Stargardt macular dystrophy-fundus flavimaculatus.

Lois N, Halfyard AS, Bird AC, Holder GE, Fitzke FW.

Am J Ophthalmol. 2004 Jul;138(1):55-63.

PMID:
15234282
48.

Comparing rod and cone function with fundus autofluorescence images in retinitis pigmentosa.

Robson AG, Egan C, Holder GE, Bird AC, Fitzke FW.

Adv Exp Med Biol. 2003;533:41-7. No abstract available.

PMID:
15180246
49.

Magnification changes in scanning laser tomography.

Tan JC, Poinoosawmy D, Fitzke FW, Hitchings RA.

J Glaucoma. 2004 Apr;13(2):137-41.

PMID:
15097259
50.

An atypical phenotype of macular and peripapillary retinal atrophy caused by a mutation in the RP2 gene.

Dandekar SS, Ebenezer ND, Grayson C, Chapple JP, Egan CA, Holder GE, Jenkins SA, Fitzke FW, Cheetham ME, Webster AR, Hardcastle AJ.

Br J Ophthalmol. 2004 Apr;88(4):528-32.

Supplemental Content

Loading ...
Support Center